Browse by Medical Category
Areej El-Jawahri MD is an Instructor of Medicine at Harvard Medical School, Director of the Bone Marrow Transplant Survivorship Program at the Massachusetts General Hospital, and Associate Director of Massachusetts General Hospital Cancer Center Survivorship Program. Dr. El-Jawahri’s research focuses on improving the quality of life and care for patients with hematologic malignancies and their families, and addressing their palliative and supportive care and survivorship needs.
Dr. El-Jawahri is an oncologist specializing in the care of patients with hematologic malignancies and those undergoing hematopoietic stem cell transplantation. Her research goal is to improve the quality of life and care for patients with hematologic malignancies and their families. Dr. El-Jawahri’s research interests include investigating patient-reported outcomes, developing interventions to enhance patient-centered decision-making, and designing supportive and palliative care interventions to improve the care of patients with hematologic malignancies and their families.
She is also interested in exploring models of health care delivery to improve patients’ quality of life and end of life care and to enhance their prognostic understanding. Over the past several years, Dr. El-Jawahri has conducted numerous studies to explore patients’ and families’ prognostic understanding and develop video decision aids to promote patient-centered decision-making.
She has also studied extensively the supportive care needs of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation and is currently conducting a randomized clinical trial of a palliative care intervention for this population. Additionally, Dr. El-Jawahri has several ongoing studies developing and testing the efficacy of various interventions to improve the quality of life and care of hematopoietic stem cell transplant survivors and their families. These interventions target specific issues experienced by survivors such as sexual dysfunction and psychological distress.
Dr. El-Jawahri’s future goals are to continue to develop innovative interventions to improve the quality of life, prognostic understanding, patient-centered decision-making, and overall care of patients with hematologic malignancies throughout their illness trajectory.
Back to Top